$AXON

SMITH PATRICK W sold $6.4M of AXON

SMITH PATRICK W (CHIEF EXECUTIVE OFFICER) sold 10,000 shares of AXON ENTERPRISE, INC. (AXON) at an average of $643.79 ($626.78–$662.70, $6.44M total) across 26 trades on 2026-07-07 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · SMITH PATRICK W
Published Jul 9, 2026, 9:09 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 9, 2026, 9:14 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$AXON
Neutral
medium confidence
Mentioned
$AXON
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$AXONNeutralLow
01

Why it matters

Traders may briefly reassess sentiment around Axon, but without any accompanying earnings, guidance, legal, or product catalyst, the decision value is limited.

02

Market read

A new, primary-source insider sale disclosure for Axon, with 10b5-1 pre-arrangement noted, implying routine execution rather than new negative information.

03

What to watch

The filing does not disclose reasons for the sale, and the net holdings after the transaction remain very large (3.04M shares), which can mute the signal.

Relevance 5/10Novelty 6/10Timing: after-hours, new SEC Form 4 disclosure filed 2026-07-09

Background

The filing is an SEC Form 4 insider transaction by Axon’s CEO, reported as an open-market sale executed across 26 trades.

Company-level read

Ticker impact

$AXONNeutralMedium confidence
Context

Axon CEO Smith Patrick W sold about 10,000 shares in an open-market transaction totaling $6.44M, per a fresh SEC Form 4 filed today.

Expected impact

Likely limited immediate price impact; any reaction should be modest unless accompanied by other company-specific news.

Evidence & confidence

The article provides a primary-source Form 4 with transaction size and pricing range, but no accompanying operational or guidance change. The presence of a 10b5-1 plan suggests routine execution rather than new negative information.

Market effects

Minimal; this is company-specific insider activity with no stated sector-wide catalyst.

None indicated.

None indicated.

Counterpoint

The sale may be purely liquidity-driven and scheduled under a 10b5-1 plan, so it should not be treated as a bearish fundamental signal.

Key entities

  • AXON ENTERPRISE, INC.

    Subject of the Form 4 insider sale by its CEO.

  • SMITH PATRICK W

    Chief Executive Officer who sold shares totaling $6.44M.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$AXONHighAI 9/10

Axon’s (AXON) Dilution Fears Look Overstated

Axon Enterprise (AXON) stock fell after announcing a $1B convertible-note offering, but analysts argue dilution fears are overstated. The notes carry 0% interest, convert at $652.06, and are hedged to $1,049.94. Q2 revenue rose 35% to $904M, marking 10 straight quarters of over 30% growth. Management raised full-year revenue growth outlook to 32-34%. AXON has a Strong Buy consensus rating, with an average price target of $719.55.

$AXONHighAI 8/10

Why Did Axon Stock Fall Ten Percent On A Convertible That Pays No Interest?

Axon Enterprise (AXON) shares dropped 9.8% after announcing a $1.0 billion convertible note offering with a 0% coupon. The market interpreted this as a sign of cash flow challenges despite strong revenue growth (34.6% YoY). The company cited inventory investments and rising component costs. AXON's stock is now 43% below its 52-week high, trading at 11x trailing revenue with shrinking margins.

$AXONHighAI 9/10

Axon Q2FY26 Results: Revenue rises 35% to $904 million, guidance raised

Axon Enterprise reported Q2FY26 revenue of $904M, up 35% YoY, and raised full-year guidance to 32-34% growth. Software & services revenue rose 36% to $398M, while connected devices revenue grew 35% to $507M. Platform solutions revenue surged 123% to $150M. The company plans a $1B convertible note offering due 2031, with net proceeds for general corporate purposes and capped call transactions. Shares were up 0.50% in premarket trading.

$AXONHighAI 8/10

Full Transcript: Axon Enterprise Q2 2026 Earnings Call - (AXON)

Axon Enterprise (AXON) reported a record Q2 2026 with 39% growth, driven by demand for Dedrone, Taser 10, and Axon Body 4. The company raised its full-year revenue guidance to 32-34% growth, citing strong bookings and market expansion. Management highlighted investments in AI and public safety technologies, emphasizing trust and data privacy.

$AXONMedAI 8/10

Axon Rebounded 6% Wednesday. Here’s What Could Drive the Stock Through 2026

Axon Enterprise's stock rebounded 6% to $468 on Wednesday after a 10% drop following a $1 billion convertible notes offering. The company expects 32-34% revenue growth in 2026, with strong Q4 growth anticipated. Analysts maintain bullish targets, citing Axon's faster expansion compared to competitors like Motorola Solutions. The stock has an implied upside of 56% based on a valuation model target of $706.